We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
New Products.
- Abstract
This article presents information related to several products launched recently. Amgen Inc. and Wyeth Pharmaceuticals Inc. announced the new 50 mg/mL prefilled syringe of Enbrel® has been approved by the FDA as the recommended dosing form for treatment in all approved adult indications. Galderma Laboratories Inc. has announced the introduction of Cetaphil® Therapeutic Hand Cream, the newest product to join their line of cleansers and moisturizers. 3M Co. announced that the FDA has approved the first prescription therapy in nearly a decade for treating superficial basal cell carcinoma.
- Subjects
NEW product development; AMGEN Inc.; WYETH Pharmaceuticals Inc.; SYRINGES; GALDERMA Laboratories LP; 3M Co.
- Publication
Dermatology Nursing, 2004, Vol 16, Issue 6, p549
- ISSN
1060-3441
- Publication type
Article